- Home
- CCLD vs VERU Comparison
CCLD vs VERU Comparison
Compare CCLD & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCLD
- VERU
- Stock Information
- Founded
- CCLD 1999
- VERU 1971
- Country
- CCLD United States
- VERU United States
- Employees
- CCLD N/A
- VERU N/A
- Industry
- CCLD Computer Software: Prepackaged Software
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- CCLD Technology
- VERU Health Care
- Exchange
- CCLD Nasdaq
- VERU Nasdaq
- Market Cap
- CCLD 105.8M
- VERU 85.5M
- IPO Year
- CCLD 2014
- VERU 1990
- Fundamental
- Price
- CCLD $2.40
- VERU $0.60
- Analyst Decision
- CCLD Buy
- VERU Strong Buy
- Analyst Count
- CCLD 2
- VERU 2
- Target Price
- CCLD $3.00
- VERU $4.00
- AVG Volume (30 Days)
- CCLD 488.2K
- VERU 2.5M
- Earning Date
- CCLD 08-12-2025
- VERU 08-07-2025
- Dividend Yield
- CCLD N/A
- VERU N/A
- EPS Growth
- CCLD N/A
- VERU N/A
- EPS
- CCLD N/A
- VERU N/A
- Revenue
- CCLD $112,507,000.00
- VERU $16,886,419.00
- Revenue This Year
- CCLD $2.74
- VERU N/A
- Revenue Next Year
- CCLD $7.52
- VERU N/A
- P/E Ratio
- CCLD N/A
- VERU N/A
- Revenue Growth
- CCLD N/A
- VERU 134.43
- 52 Week Low
- CCLD $1.14
- VERU $0.45
- 52 Week High
- CCLD $4.84
- VERU $1.42
- Technical
- Relative Strength Index (RSI)
- CCLD 55.83
- VERU 50.99
- Support Level
- CCLD $2.29
- VERU $0.54
- Resistance Level
- CCLD $2.48
- VERU $0.60
- Average True Range (ATR)
- CCLD 0.15
- VERU 0.04
- MACD
- CCLD -0.01
- VERU -0.01
- Stochastic Oscillator
- CCLD 53.13
- VERU 31.05
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. The company provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.